Covid-19 infection and arterial hypertension: the relationship between the two entities

Covid-19 infection and arterial hypertension: the relationship between the two entities

Background: The aim of the study was to breakdown the relationship and its nature between the two pathological entities arterial hypertension (AHT) and SARS-CoV-2 infection. The analysis of existing literature on both topics has been conducted. Sources including journals, books, existing publication...

Full description

Bibliographic Details
Main Authors:	Svetlana Gavriliuc, Abhinand Sanalkumar, Sneha Jeevan, Ghenadie Calin, Diana Sasu
Format:	Article
Language:	English
Published:	Scientific Medical Association of Moldova 2023-12-01
Series:	The Moldovan Medical Journal
Subjects:	sars-cov-2 infection arterial hypertension raas raas inhibitors
Online Access:	https://moldmedjournal.md/wp-content/uploads/2023/12/moldovan-med-j-2023-66-2-gavriliuc-et-al-full-text.pdf

Similar Items

Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy
by: O L Barbarash, et al.
Published: (2013-12-01)

The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
by: Yu V Zhernakov, et al.
Published: (2014-12-01)

A cross-sectional study on factors associated with hypertension and genetic polymorphisms of renin-angiotensin-aldosterone system in Chinese hui pilgrims to hajj
by: Yinxia Zhang, et al.
Published: (2019-09-01)

The potential role of RAAS-related hsa_circ_0122153 and hsa_circ_0025088 in essential hypertension
by: Xin He, et al.
Published: (2021-11-01)

Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients
by: Anja Pfaue, et al.
Published: (2019-11-01)

The effect of renin–angiotensin–aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies
by: Kai Zhang, et al.
Published: (2022-10-01)

The effect of hypertension and antihypertensive therapies on the course of COVID-19 infection: Turkish national health system data
by: Gülsüm Özkan, et al.
Published: (2022-08-01)

A Reverse Transcription Recombinase-Aided Amplification Method for Rapid and Point-of-Care Detection of SARS-CoV-2, including Variants
by: Fengyun Li, et al.
Published: (2021-09-01)

The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations
by: Minela Aida Maranduca, et al.
Published: (2022-11-01)

Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension
by: Robin Shoemaker, et al.
Published: (2023-11-01)

MONO- OR COMBINED ANTIHYPERTENSIVE THERAPY IN WOMEN WITH ARTERIAL HYPERTENSION AND MODERATE RISK OF CARDIOVASCULAR DISEASES: WHAT’S BETTER?
by: R. I. Stryuk, et al.
Published: (2018-01-01)

Chymase Dependent Pathway of Angiotensin II Generation and Rapeseed Derived Peptides for Antihypertensive Treatment of Spontaneously Hypertensive Rats
by: Iwona Baranowska, et al.
Published: (2021-05-01)

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
by: Elisa Russo, et al.
Published: (2023-05-01)

The efficacy and safety of dual blockage of the renin-angiotensin-aldosterone system in patients with type 2 diabetes, hypertension and obesity without renal dysfunction
Published: (2012-09-01)

Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review
by: Taylor J. Louis, et al.
Published: (2022-01-01)

The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020-08-01)

Establishment of two assays based on reverse transcription recombinase-aided amplification technology for rapid detection of H5 subtype avian influenza virus
by: Yang Li, et al.
Published: (2023-12-01)

Emergency endovascular stent-graft repair of a traumatic ruptured renal artery aneurysm: A case report
by: Wesam Elbaroni, et al.
Published: (2021-09-01)

RAASi Therapy Attenuates the Association between 24-h Urinary Potassium Excretion and Dietary Potassium Intake in CKD Patients
by: Domenico Giannese, et al.
Published: (2023-05-01)

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
by: Joseph B. Muhlestein, et al.
Published: (2021-02-01)

Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm
by: Filippos Triposkiadis, et al.
Published: (2021-05-01)

Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials
by: Samuel Seidu, et al.
Published: (2022-01-01)

Aldosterone-progesterone relationship in sexually intact Chihuahua bitches
by: Alberto Galizzi, et al.
Published: (2023-09-01)

Think twice before stent insertion for renal artery aneurysm with elusive etiology: a case report
by: Jian-zhong Zhang, et al.
Published: (2019-10-01)

Do Changes in <i>ACE-2</i> Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
by: Huseyin C. Yalcin, et al.
Published: (2021-06-01)

A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency
by: Elizabeth M. Sajdel-Sulkowska
Published: (2021-06-01)

Renin–Angiotensin–Aldosterone System: From History to Practice of a Secular Topic
by: Sara H. Ksiazek, et al.
Published: (2024-04-01)

A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets
by: Pia V. Sodhi, et al.
Published: (2022-12-01)

Hormonal Blood Pressure Regulation during General Anesthesia Using a Standardized Propofol Dosage in Children and Adolescents Seems Not to Be Affected by Body Weight
by: Gunther Hempel, et al.
Published: (2020-07-01)

Chemical Synthesis, Safety and Efficacy of Antihypertensive Candidate Drug 221s (2,9)
by: Bei Qin, et al.
Published: (2023-06-01)

Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
by: Sarnowski A, et al.
Published: (2022-08-01)

Clinical Characteristics and Inflammatory Immune Responses in COVID-19 Patients With Hypertension: A Retrospective Study
by: Chaoran Wu, et al.
Published: (2021-10-01)

A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database
by: Sharma A, et al.
Published: (2020-11-01)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
by: Melissa Coffman, et al.
Published: (2021-07-01)

Enhancement of the serum chloride concentration by administration of sodium–glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: a pilot study
by: Hajime Kataoka, et al.
Published: (2020-01-01)

Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study
by: Lucia Barbieri, et al.
Published: (2021-12-01)

A case control association study of ACE gene polymorphism (I/D) with hypertension in Punjabi population from Faisalabad, Pakistan
by: Misbah Hussain, et al.
Published: (2018-02-01)

ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
by: Akçahan GEPDİREMEN, et al.
Published: (2020-12-01)

Identifying pathophysiological bases of disease in COVID-19
by: Carla J. Goldin, et al.
Published: (2020-09-01)

Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
by: Hamideh Amirfakhryan, et al.
Published: (2021-01-01)